Correlation of number of tumor buds and tumor stage in large bowel carcinomas

Branislav Djerkovic ,
Branislav Djerkovic
Milica Mijovic ,
Milica Mijovic
Danica Vukicevic ,
Danica Vukicevic
Mihajlo Vukmirovic ,
Mihajlo Vukmirovic
Leonida Vitkovic ,
Leonida Vitkovic
Vladica Nedeljkovic
Vladica Nedeljkovic

Published: 01.06.2016.

Volume 45, Issue 2 (2016)

pp. 7-11;

https://doi.org/10.5937/pramed1602007d

Abstract

Standardized staging of tumors takes into account the depth of invasion of the intestinal wall and the presence of local or distant metastases, specifically focusing to precisely estimate length of patient survival. This assessment system does not fully reflect the biological behaviour of cancer individually, ie. tumor aggressiveness and ability of recurrence tumor after medical treatment. Futuremore, cancer at some patients have more aggressive growth than other carcinomas in the same clinical stage, because there are other parameters that determine the biological behaviors of colon cancer, which are not included in the standard classification of determining tumor stage. One of the recent arguments which are due in the spotlight is "tumor budding", which represents one cell or group of up to five non-differentiated tumor cells, which are found in the stroma out of the invasive front line of cancer. There are 92 colon cancer and upper rectum processed, which are collected at General Hospital in Trebinje and Medical Center in Kosovska Mitrovica. The aim is to determine whether there is a correlation between the number of tumor budding and stage of tumors in colorectal cancer. The tumor stage is determined by Astler Coller classification. Investigation, based on χ2-test, leads to the conclusion that there is not a statistical significance in tumor budding distribution in relation to tumor stage according to the Astler Coller classification (p = 0.383; p> 0.05).

Keywords

References

1.
Fletcher C. Diagnostic Histopathology of Tumors, 2nd Edition. Churcill Livingstone. 2004;389–90.
2.
Kumar V, Cotran R, Robbins S, Basic. Pathology. 2003;
3.
Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well -or moderately differentiated rectal adenocarcinoma. J Surg Oncol. 2003;42–7.
4.
Park K, Choi H. Intensity of Tumor Budding and Its Prognostic Implications in Invasive Colon Carcinoma. Dis Colon Rectum. 2005;1597–602.
5.
Ueno H, Murphy J, Jass J. Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;127–32.
6.
Broders A. Squamous-cell epithelioma of the lip. A study of five hundred and thirty-seven cases. J Am Med Assoc. 1920;656–64.
7.
Nabeshima K, Inoue T, Snimano Y. Cohort migration of carcinoma cells: Differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol. 1999;1183–97.
8.
Morodomi T, Isomoto H, Shirouzu K. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer. 1989;539–43.
9.
Shinto E, Jass J. Differential Prognostic Significance of Morphologic Invasive Markers in Colorectal Cancer: Tumor Budding and Cytoplasmic Podia. Dis Colon Rectum. 2006;1422–30.
10.
Okuyama T, Oya M. Budding (Sprouting) as a Useful Prognostic Marker in Colorectal Mucinous Carcinoma. Jpn J Clin Oncol. 2002;(10):412–6.
11.
Okuyama T, Nakamura T, Yamaguchi M. Budding is useful to select high-risk patients in Stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis Colon Rectum. 2003;1400–6.
12.
Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well -or moderately -differentiated rectal adenocarcinoma. J Surg Oncol. 2003;(1):42–7.
13.
Park K, Choi H. Intensity of Tumor Budding and Its Prognostic Implications in Invasive Colon Carcinoma. Dis Colon Rectum. 2005;1597–602.
14.
Choi H, Park K. Tumor budding as a prognostic marker in stage-III rectal carcinoma. Int J Colorectal Dis. 2007;(8):863–8.
15.
Hase K, Shatney C, Johnson D. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum. 1993;627–35.
16.
Hase K, Shatney C, Mochizuki H. Long-term results of curative resection of “minimally invasive” colorectal cancer. Dis Colon Rectum. 1995;19–26.
17.
Masaki T, Matsuoka H, Sugiyama M. Budding as a useful determinant of the optimal treatment for Tl rectal carcinomas. Hepatogastroenterology. 2003;388–91.
18.
Masaki T, Matsuoka H. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol. 2006;(7):1115–21.
19.
Kazama S, Watanabe T. Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. British Journal of Cancer. 2006;293–8.
20.
Kaneko I, Tanaka S. Lymphatic Vessel Density at the Site of Deepest Penetration as a Predictor of Lymph Node Metastasis in Submucosal Colorectal Cancer. Dis Colon Rectum. 2006;13–21.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by